Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBD oil for endometriosis symptoms
ACTRN12624000828527Phase 2Withdrawn
- Sponsor
- Western Sydney University
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in endometriosis comparing CBD oil with Placebo oil (2 arms). Primary endpoint: Composite primary outcome: endometriosis symptom severity and biomarker/microbiome changes. Planned start Sep 2025; status: withdrawn.
02
Drugs
cannabidiol
03
Conditions
endometriosis
Beyond the preview
Go deeper on ACTRN12624000828527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12624000828527.